REGISTERED NUMBER: 11569053 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 March 2026

for

Griffin Neurosurgery Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

J R Goodden

Mrs H T Goodden

REGISTERED OFFICE:

Suite 12 Jason House

Kerry Hill

Horsforth

Leeds

West Yorkshire

LS18 4JR

REGISTERED NUMBER:

11569053 (England and Wales)

ACCOUNTANTS:

Yorkshire Medical Accountants LLP

Suite 12

East Wing, Jason House

Kerry Hill, Horsforth

Leeds

West Yorkshire

LS18 4JR

FIXED ASSETS

Tangible assets

4

19,011

17,506

CURRENT ASSETS

Debtors

5

38,016

57,803

Investments

6

149,035

110,804

Cash at bank and in hand

298,845

239,145

485,896

407,752

CREDITORS

Amounts falling due within one year

7

69,100

59,336

NET CURRENT ASSETS

416,796

348,416

TOTAL ASSETS LESS CURRENT LIABILITIES

435,807

365,922

PROVISIONS FOR LIABILITIES

4,753

4,377

NET ASSETS

431,054

361,545

CAPITAL AND RESERVES

Called up share capital

104

104

Retained earnings

430,950

361,441

SHAREHOLDERS' FUNDS

431,054

361,545

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20 May 2026 and were signed on its behalf by:

J R Goodden - Director

Mrs H T Goodden - Director

1.	STATUTORY INFORMATION

Griffin Neurosurgery Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

33% on cost and 25% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2025 - 4 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 April 2025

101,417

Additions

6,773

Disposals

(4,327

)

At 31 March 2026

103,863

DEPRECIATION

At 1 April 2025

83,911

Charge for year

5,084

Eliminated on disposal

(4,143

)

At 31 March 2026

84,852

NET BOOK VALUE

At 31 March 2026

19,011

At 31 March 2025

17,506

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.26

31.3.25

£

£

Trade debtors

37,135

56,862

Other debtors

881

941

38,016

57,803

6.	CURRENT ASSET INVESTMENTS

31.3.26

31.3.25

£

£

Listed investments

149,035

110,804

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.26

31.3.25

£

£

Bank loans and overdrafts

7,061

4,935

Trade creditors

9

9

Taxation and social security

59,434

51,917

Other creditors

2,596

2,475

69,100

59,336

8.	RELATED PARTY DISCLOSURES

During the year, total dividends of £21,000 (2025 - £18,000) were paid to the directors .

Included in other creditors at the year end are amounts owing to the directors of £690 (2025 - £672).